| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 105,256 | 112,296 | | Cost of Revenue | 95,357 | 93,884 | | | Gross Profit | 9,899 | 18,412 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 13,733 | 15,107 | | Non Recurring | 7,457 | 2,391 | | Others | 2,754 | 3,761 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (14,045) | (2,847) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 43 | 53 | | Earnings Before Interest And Taxes | (14,002) | (2,794) | | Interest Expense | 1,306 | 1,146 | | Income Before Tax | (15,308) | (3,940) | | Income Tax Expense | (509) | (834) | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (14,799) | (3,106) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (14,799) | (3,106) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($14,799) | ($3,106) |
|
1.48% Nasdaq 
0.04 (2.80%) 
Income Statement
